Search results for "Inhalation"

showing 10 items of 326 documents

Secretion of neutral and acid DNases in cultivated human lymphocytes after incubation with DNA; possible consequences for inhalation anesthesia.

1995

Abstract After incubation with DNA human lymphocytes release neutral and acid DNase activities into the culture medium; the release depends on DNA concentration and time of cultivation. The electrophoretic mobility of the released neutral DNase activity is in accordance with DNase I and the electrophoretic mobility of the released acid DNase activity with DNase II. The released DNase activities do not originate from dead cells and are not influenced by blast cell formation. The anesthetic halothane can inhibit the released neutral and acid DNase activities. Inhalation anesthesia can possibly disturb the correlation between DNA and DNases in human blood.

Time FactorsBiologyGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundPrecursor cellmedicineDeoxyribonuclease IHumansSecretionLymphocytesIncubationCells CulturedDeoxyribonucleasesEndodeoxyribonucleasesInhalationDose-Response Relationship DrugDNAHydrogen-Ion ConcentrationDose–response relationshipKineticschemistryBiochemistryAnestheticHalothaneAnesthesia InhalationHalothaneDNAmedicine.drugZeitschrift fur Naturforschung. C, Journal of biosciences
researchProduct

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD

2012

Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). Long-acting muscarinic antagonists (LAMAs) and long-acting β(2)-agonists (LABAs) are the main classes of long-acting bronchodilators. To date, tiotropium is the only once-daily LAMA available for the treatment of COPD. Glycopyrronium is a novel LAMA, currently in development for COPD. Phase II studies have shown that glycopyrronium 50 μg once daily provides clinically significant 24-hour bronchodilation with a rapid onset of action, which is faster than that of tiotropium, and a favorable safety and tolerability profile. The Phase III GLycopyrronium bromide in COPD airWays (GLOW) progr…

Time FactorsCombination therapymuscarinic antagonistReviewMuscarinic AntagonistsPlaceboNVA237Severity of Illness IndexDrug Administration Schedulechronic obstructive pulmonary diseaseglycopyrroniumPulmonary Disease Chronic ObstructiveAdministration InhalationHumansMedicineGlycopyrronium bromideAdverse effectLungCOPDExercise Tolerancebiologybusiness.industryGeneral MedicineLamamedicine.diseasebiology.organism_classificationonce dailyGlycopyrrolateBronchodilator Agentsrespiratory tract diseasesTreatment OutcomeTolerabilityAnesthesiaIndacaterolbusinessmedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

The Hip Fracture Surgery in Elderly Patients (HIPELD) study: protocol for a randomized, multicenter controlled trial evaluating the effect of xenon o…

2012

Trials 13, 180 (2012). doi:10.1186/1745-6215-13-180

Time FactorsXenonCost-Benefit AnalysisMedicine (miscellaneous)Hospital CostHip fracturelaw.inventionStudy ProtocolFracture Fixation InternalRandomized controlled triallawFracture fixationAge FactorPharmacology (medical)Prospective StudiesHospital CostsProspective cohort studylcsh:R5-920Hip fractureDrug CostIncidence (epidemiology)Age FactorsPostoperative deliriumPsychiatric Status Rating ScaleEuropeTreatment OutcomeResearch DesignAnesthesiaAnesthetics Inhalationmedicine.symptomlcsh:Medicine (General)Humanmedicine.drugMethyl Ethersmedicine.medical_specialtyTime FactorDrug CostsSevofluraneSevofluranemedicineHumansCost-Benefit AnalysiAgedPsychiatric Status Rating ScalesHip Fracturesbusiness.industryDeliriummedicine.diseaseSurgeryClinical trialProspective StudieMethyl EtherDeliriumbusinessTrials
researchProduct

Valoración del manejo de los inhaladores por el personal de enfermería en un hospital de referencia

2008

Objetivo: valorar los conocimientos y adiestramiento del personal de enfermería con el paciente respiratorio en el manejo de la terapia inhalada en distintas salas de hospitalización. Material y métodos: se diseñó un estudio prospectivo con 144 enfermos/as mediante una encuesta individual en la que se solicitó a cada uno de ellos una demostración práctica del manejo del cartucho presurizado con cámara inhalatoria, sin realizar una instrucción teórica previa sobre la técnica. Se revisó la técnica inhalatoria siguiendo los pasos establecidos en la normativa SEPAR. Resultados: participaron 144 de los 177 enfermeros/as (81,4%) que trabajan en las diferentes salas de hospitalización (29 varones,…

Técnica de inhalaciónConocimientosInhalationbusiness.industryCross-sectional studyInhalerMean ageInhalation techniqueHealth personnelInhalation chamberNursingInternal MedicineMedicineEPOCbusinessShort Stay UnitAsma
researchProduct

Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-prop…

2012

Objectives For practical reasons, patients with cystic fibrosis (CF) tend to mix different inhalation solutions for concomitant inhalation instead of inhaling the different medications consecutively. A study was undertaken to examine the compatibility of colistimethate dissolved in 5.85% hypertonic sodium chloride (NaCl) solution and the quadripartite mixtures of colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate. Methods The test solutions were prepared by mixing ordinary doses of the inhalation products and analysed immediately. Microbiological assays of antibiotics and high-performance liquid chromatography assays were used to determine chemical compati…

chemistry.chemical_classificationChromatographyInhalationChemistryIpratropium bromideAntimicrobialHypertonic salineAnesthesiamedicinePropionateGeneral Pharmacology Toxicology and PharmaceuticsSalbutamol sulfateColistimethateFluticasonemedicine.drugEuropean Journal of Hospital Pharmacy
researchProduct

Leukocytoclastic vasculitis associated with sulfuric acid inhalation

2013

chemistry.chemical_compoundmedicine.medical_specialtyInhalationchemistrybusiness.industryLeukocytoclastic vasculitisMedicineSulfuric acidDermatologybusinessDermatologyInternational Journal of Dermatology
researchProduct

Spacers and Valved Holding Chambers—The Risk of Switching to Different Chambers

2020

© 2020 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

corticosteroidSpacerinhalation spacerQ1lung03 medical and health sciences0302 clinical medicineDrug Delivery SystemsdysphoniaRC705InhalersAdministration InhalationImmunology and AllergyMedicineHumansmetered dose inhaler030212 general & internal medicineMetered Dose InhalershumanParticle Sizesnoutbusiness.industryInhaleradultthroat irritationInhalerarticleValved holding chamberrisk assessmentR735Equipment DesignReduced doseValved Holding ChambersMetered-dose inhalerthrushR1030228 respiratory systemDelivery systembusinessvalveBiomedical engineeringInhalation Spacers
researchProduct

Evaluation of Dysphagia and Inhalation Risk in Neurologically Impaired Children Using Esophageal High-Resolution Manometry with Swallowing Analysis

2022

Background: Dysphagia in neurologically impaired children is associated with feeding difficulties, malnutrition and aspiration pneumonia. Esophageal high-resolution manometry (HRM) has been used in the diagnosis of motility disorders affecting the swallowing process. The aim of this study was to analyze swallowing functions in NI children by using HRM in order to establish swallow parameters identifying inhalation risk. Methods: Twenty-five NI children with cerebral palsy were submitted to esophageal HRM with UES analysis, comparing the results with non-NI children. The following parameters were evaluated: maximum pressure and duration of contraction of the velopharynx (VP) and tongue base …

high-resolution manometry inhalation neurological children dysphagiaSettore MED/20 - Chirurgia Pediatrica E InfantilePediatrics Perinatology and Child Healthneurological children; dysphagia; inhalation; high-resolution manometryChildren; Volume 9; Issue 12; Pages: 1987
researchProduct

High flow nasal therapy in Acute Exacerbation of COPD: Ready for the prime time?

2021

medicine.medical_specialtyCOPD2019-20 coronavirus outbreakNoninvasive VentilationExacerbationCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Oxygen Inhalation TherapyPulmonary diseaseGeneral Medicinemedicine.diseasePulmonary Disease Chronic ObstructiveEmergency MedicineCOPDHumansMedicineNoninvasive ventilationbusinessIntensive care medicineHigh flowThe American Journal of Emergency Medicine
researchProduct

How Can We Assess the Perception of Induced Dyspnea in Chronic Obstructive Pulmonary Disease?

2004

Objective TO evaluate various methods for studying the perception of dyspnea in chronic obstructive pulmonary disease (COPD) using a new parameter, the change in Borg scale rating, and others already in use: the linear regression slope and the application of Stevens' law to the response-perception curve-ie change in forced expiratory volume in 1 second (ΔFEV 1 )-change in dyspnea (Adyspnea). Patients and method A bronchial challenge test was performed on 70 patients with stable COPD and no contraindications for performing the test (European Respiratory Society criteria), during which dyspnea was measured (Borg scale) after each nebulization. Perception was analyzed using: a ) the linear reg…

medicine.medical_specialtyCOPDgenetic structuresInhalationmedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectPulmonary diseaseBronchial provocation testsGeneral Medicinemedicine.diseaserespiratory tract diseasesPerceptionSeverity of illnessPhysical therapyMedicineBronchial challenge testsense organsbusinessmedia_commonArchivos de Bronconeumología ((English Edition))
researchProduct